A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
11/2007
11/14/2007	CN100348580C Taxol enhancer compounds
11/14/2007	CN100348265C Controlled release composition and method of producing the same
11/14/2007	CN100348186C Compounds for the treatment of metabolic disorders
11/13/2007	US7294687 For alleviating symptoms of systemic lupus erythematosus (SLE) in a human subject
11/13/2007	US7294352 Matrix protein composition for treating inflammation
11/13/2007	US7294056 Enhanced gaming system
11/13/2007	CA2402707C Use of cdp-choline for the treatment of alcohol withdrawal syndrome
11/08/2007	WO2005009394A3 Drug delivery in the nervous system
11/08/2007	US20070260058 N-phenyl-1,3-thiazol-2-amine derivatives, useful in the treatment of neurodegenerative disorders, such as Alzheimer's disease
11/08/2007	US20070259956 Compositions and methods for treating cancer
11/08/2007	US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents
11/08/2007	US20070259873 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide
11/08/2007	US20070259852 Such as 2-(2-hydroxycarbamoylmethyl-3-oxo-2,3-dihydro-benzo[1,4]thiazin-4-yl)-propionamide; peptidyl deformylase (PDF) inhibitors; for treatment of bacterial infections
11/08/2007	US20070259844 Antiviral Compositions And Methods Of Using The Same
11/08/2007	US20070259014 Compositions for and Methods for Treating Hiv
11/08/2007	US20070258893 Compositions and methods for imaging expression of cell surface receptors
11/07/2007	EP1664033B1 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof
11/07/2007	EP1575520B1 A process for preparation of an agglutination reagent for rapid detection of typhoid
11/07/2007	CN101068601A Polyamine compositions
11/07/2007	CN101068569A Anti-cancer virus desensitization method
11/07/2007	CN101066952A Crystalline pharmaceutical
11/07/2007	CN101066447A Group b streptococcus proteins, and their use
11/07/2007	CN100346769C Dyeing composition for keratinous fibres with direct cationic colouring agent and a quaternary ammonium salt
11/06/2007	US7292893 Apparatus and method for the treatment of infectious disease in keratinized tissue
11/06/2007	US7291744 N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
11/06/2007	US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/06/2007	US7291620 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease
11/06/2007	US7291615 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
11/06/2007	US7291350 Compositions for diabetes treatment and prophylaxis
11/06/2007	CA2451519C Tablet comprising cetirizine and pseudoephedrine
11/01/2007	WO2005004795A3 Compositions and methods for targeted drug delivery
11/01/2007	US20070255140 Echogenic coatings with overcoat
11/01/2007	US20070254918 Dopamine-, Norepinephrine- and Serotonin- Transporter-Selective Heterocyclic Compounds and Their Therapeutic Applications
11/01/2007	US20070254850 Methods for Treating and Preventing Apoptosis-Related Diseases Using Rna Interfering Agents
11/01/2007	US20070254836 Glycopegylated Granulocyte Colony Stimulating Factor
11/01/2007	US20070254835 Composition and method for treating neurological disorders
11/01/2007	US20070254834 Glycopegylated Erythropoietin
11/01/2007	US20070253945 lysozyme produced from a Chalaropsis species of fungi, having a corrected amino acid sequence so as to allow recombinant production of this enzyme with a higher activity; antibacterial agent in applications wherein killing of highly resistant bacteria such as methicillin-resistant is desired
11/01/2007	US20070253913 Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
10/2007
10/31/2007	EP1849797A2 Peptidomimetic protease inhibitors
10/31/2007	EP1849480A2 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
10/31/2007	EP1849359A1 Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom
10/31/2007	EP1687405A4 Ttbks as modifiers of the beta catenin pathway and methods of use
10/31/2007	CN101065118A A composition comprising at least 3 different diols
10/31/2007	CN101062940A Inhibitor of stem cell proliferation and uses thereof
10/31/2007	CN101062415A Use of IL-18 inhibitors
10/31/2007	CN101062056A Low concentration of peroxide for treating or preventing vaginal infection
10/31/2007	CN101062037A Thioxanthine derivatives, process for their preparation (variants), their use and composition containing them
10/31/2007	CN100345844C Quinazoline derivatives for the treatment of tumours
10/30/2007	US7288559 Carboxamide spirohydantoin CGRP receptor antagonists
10/30/2007	US7288529 ALK protein tyrosine kinase, cells and methods embodying and using same
10/30/2007	US7288383 Eosinophil-derived neurotoxin as a marker for ovarian cancer
10/30/2007	US7288225 Psyllium plant extracts; constipation therapy, gastrointestinal disorders
10/30/2007	CA2509650C C-6 modified indazolylpyrrolotriazines
10/30/2007	CA2318216C Dual component antiplaque dentifrice composition
10/30/2007	CA2145397C Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
10/25/2007	WO2005034877A3 G-csf transferrin fusion proteins
10/25/2007	US20070250084 Components, systems, and methods for forming anastomoses using magnetism or other coupling means
10/25/2007	US20070249833 such as 2-bromo-1-[6-(4-methyl-imidazole-1-yl)-pyridin-3-yl]-ethanone, which have activity in modulating levels of amyloid-beta, useful in the treatment of neurodegenerative diseases, such as Alzheimer's disease
10/25/2007	US20070249653 Tetracyclic benzamide derivatives and methods of use thereof
10/25/2007	US20070249613 Reduction of Toxicity of Multi-Targeting Antifolates
10/25/2007	US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007	US20070248667 Tannate Compositions and Methods of Use
10/25/2007	US20070248626 Recombinant toxin fragments
10/25/2007	US20070248615 T helper cell epitopes
10/25/2007	US20070248569 Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization
10/24/2007	EP1847593A1 Method for the purification, recovery, and sporulation of cysts and oocysts
10/24/2007	EP1691761A4 A low-weight ultra-thin flexible radiation attenuation composition
10/24/2007	EP1628647A4 Novel lipids for transfection of nucleic acids
10/24/2007	EP1478401A4 Compositions comprising dietary fat complexer and methods for their use
10/23/2007	US7285526 Reducing the interferon-bioavailability by administering two isolated interferon-binding proteins, e.g., the human IFN-gamma receptor; B8R and B18R proteins of Vaccinia virus; Alzheimer's disease; Down syndrome; HIV; autoimmune diseases
10/23/2007	US7285386 Animal modeling human papillomavirus infection in a Rhesus macaque by contacting anogenital and/or cervical tissue or respiratory epithelial tissue with infectious Rhesus papillomavirus (RhPV) virions; evaluating for symptoms and/or viral replication
10/23/2007	US7285382 Compositions and methods for treatment of cancer
10/23/2007	CA2177961C Use of dimeticone for treating aphthae and stomatitis
10/18/2007	WO2007011231A3 Use of compounds comprising fatty acid entities
10/18/2007	US20070244116 c-MET MODULATORS AND METHOD OF USE
10/18/2007	US20070244078 Methods for Treatment, Modification and Management of Pain Using 1-Oxo-2-(2,6-Dioxopiperidin-3-yl)-4-Methylisoindoline
10/18/2007	US20070244076 Site and Rate Selective Prodrug Formulations of D609 with Antioxidant and Anticancer Activity
10/18/2007	US20070243629 High Affinity Ligands for Influenza Virus and Methods for Their Production
10/18/2007	US20070243187 Methods and Materials for Treating Autoimmune Diseases and Conditions
10/18/2007	US20070243159 Therapeutic Compositions and Vaccines By Glycosyl-Phosphatidylinositol (Gpi)-Anchored Cytokines and Immunostimulatory Molecules
10/17/2007	EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007	EP1204649B1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
10/17/2007	EP1073473B1 Improvements in or relating to contrast agents
10/17/2007	CN101054345A Novel bensophenone derivatives or salts thereof
10/17/2007	CN101053558A Diphenylethylene compounds and uses thereof
10/17/2007	CN100343252C Novel imidazopyridine compounds with therapeutic effect
10/17/2007	CN100343229C 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of PPAR-alpha
10/17/2007	CN100342907C Treatment of aspergillus infections with thymosin alpha 1
10/17/2007	CN100342851C Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
10/16/2007	US7282593 Withanamide and withanolide compositions and method of use thereof
10/16/2007	US7282519 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
10/16/2007	US7282518 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
10/16/2007	US7282517 Method of manufacturing glimepiride and the respective intermediate
10/16/2007	US7282477 Administering Cycstatin C homologues to inhibit transforming growth factor-beta stimulation of epithelial-mesenchymal transitions (EMT); antineoplastic agents
10/16/2007	CA2414018C 2-aminocarbonyl-9h-purine derivatives
10/16/2007	CA2214026C Pharmaceutical compositions comprising monoamine oxidase b inhibitors
10/16/2007	CA2191478C Process for removing bile salts from a patient and alkylated compositions therefor
10/11/2007	WO2007016679A3 Combination immediate release controlled release levodopa and carbidopa dosage forms
10/11/2007	WO2005051326A3 Treatment of a condition in a mammal with administration of compounds and methods of use thereof

1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 295